Stuart G. Tangye

Stuart G. Tangye

Top Cited Scholar 2026
Auto-generated profile, based on publicly available information

Stuart G. Tangye

Garvan Institute of Medical Research, Darlinghurst, Australia

Research Focus & Metrics

Academic Career Length

32Years (1995-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 October 2020 in Science
Verified
Journal Article
Open access
PDF file
PBPaul Bastard
Paul Bastard
LRLindsey B. Rosen
Lindsey B. Rosen
QZQian Zhang
Qian Zhang
EMEleftherios Michailidis
Eleftherios Michailidis
HHHans-Heinrich Hoffmann
Hans-Heinrich Hoffmann
JCJean-Laurent Casanova
Jean-Laurent Casanova
The genetics underlying severe COVID-19: The immune system is complex and involves many genes, including those that encode cytokines known as interferons (IFNs). Individuals that lack specific IFNs can be more susceptible to infectious diseases. Furthermore, the autoantibody system dampens IFN response to prevent damage from pathogen-induced inflammation. Two studies now examine the likelihood that genetics affects the risk of severe coronavirus disease 2019 (COVID-19) through components of this system (see the Perspective by Beck and Aksentijevich). Q. Zhang et al. used a candidate gene approach and identified patients with severe COVID-19 who have mutations in genes involved in the regulation of type I and III IFN immunity. They found enrichment of these genes in patients and conclude that genetics may determine the clinical course of the infection. Bastard et al. identified individuals with high titers of neutralizing autoantibodies against type I IFN-α2 and IFN-ω in about 10% of patients with severe COVID-19 pneumonia. These autoantibodies were not found either in infected people who were asymptomatic or had milder phenotype or in healthy individuals. Together, these studies identify a means by which individuals at highest risk of life-threatening COVID-19 can be identified. Science , this issue p. eabd4570 , p. eabd4585 ; see also p. 404

24 June 2022 in Journal of Clinical Immunology
Verified
Journal Article
Open access
PDF file
STStuart G. Tangye
Stuart G. Tangye
WAWaleed Al-Herz
Waleed Al-Herz
ABAziz Bousfiha
Aziz Bousfiha
CCCharlotte Cunningham-Rundles
Charlotte Cunningham-Rundles
JFJose Luis Franco
Jose Luis Franco
IMIsabelle Meyts
Isabelle Meyts
We report the updated classification of inborn errors of immunity, compiled by the International Union of Immunological Societies Expert Committee. This report documents the key clinical and laboratory features of 55 novel monogenic gene defects, and 1 phenocopy due to autoantibodies, that have either been discovered since the previous update (published January 2020) or were characterized earlier but have since been confirmed or expanded in subsequent studies. While variants in additional genes associated with immune diseases have been reported in the literature, this update includes only those that the committee assessed that reached the necessary threshold to represent novel inborn errors of immunity. There are now a total of 485 inborn errors of immunity. These advances in discovering the genetic causes of human immune diseases continue to significantly further our understanding of molecular, cellular, and immunological mechanisms of disease pathogenesis, thereby simultaneously enhancing immunological knowledge and improving patient diagnosis and management. This report is designed to serve as a resource for immunologists and geneticists pursuing the molecular diagnosis of individuals with heritable immunological disorders and for the scientific dissection of cellular and molecular mechanisms underlying monogenic and related human immune diseases.

17 January 2020 in Journal of Clinical Immunology
Verified
Journal Article
Open access
PDF file
STStuart G. Tangye
Stuart G. Tangye
WAWaleed Al-Herz
Waleed Al-Herz
ABAziz Bousfiha
Aziz Bousfiha
TCTalal Chatila
Talal Chatila
CCCharlotte Cunningham-Rundles
Charlotte Cunningham-Rundles
KSKathleen E. Sullivan
Kathleen E. Sullivan
We report the updated classification of Inborn Errors of Immunity/Primary Immunodeficiencies, compiled by the International Union of Immunological Societies Expert Committee. This report documents the key clinical and laboratory features of 430 inborn errors of immunity, including 64 gene defects that have either been discovered in the past 2 years since the previous update (published January 2018) or were characterized earlier but have since been confirmed or expanded upon in subsequent studies. The application of next-generation sequencing continues to expedite the rapid identification of novel gene defects, rare or common; broaden the immunological and clinical phenotypes of conditions arising from known gene defects and even known variants; and implement gene-specific therapies. These advances are contributing to greater understanding of the molecular, cellular, and immunological mechanisms of disease, thereby enhancing immunological knowledge while improving the management of patients and their families. This report serves as a valuable resource for the molecular diagnosis of individuals with heritable immunological disorders and also for the scientific dissection of cellular and molecular mechanisms underlying inborn errors of immunity and related human diseases.

26 September 2014 in Science
Verified
Journal Article
Closed access
PDF file
HKHye Sun Kuehn
Hye Sun Kuehn
WOWeiming Ouyang
Weiming Ouyang
BLBernice Lo
Bernice Lo
EDElissa K. Deenick
Elissa K. Deenick
JNJulie E. Niemela
Julie E. Niemela
GUGulbu Uzel
Gulbu Uzel
Beware of T cells that don't know how to stop: During an infection, T cells divide extensively and secrete proteins that can severely damage tissues. But T cells know when to stop—they express proteins on their surface such as CTLA4, which put on the brakes. Kuehn et al. now report genetic evidence of the importance of CTLA4 in humans (see the Perspective by Rieux-Laucat and Casanova). They identified six patients with mutations in one copy of CTLA4 . Patients presented with symptoms of an overzealous immune response, with immune cells infiltrating their organs. The findings support the idea that CTLA4 tells the immune system when enough is enough. Science , this issue p. 1623 ; see also p. 1560

11 December 2017 in Journal of Clinical Immunology
Verified
Journal Article
Open access
PDF file
CPCapucine Picard
Capucine Picard
HGH. Bobby Gaspar
H. Bobby Gaspar
WAWaleed Al-Herz
Waleed Al-Herz
ABAziz Bousfiha
Aziz Bousfiha
JCJean-Laurent Casanova
Jean-Laurent Casanova
KSKathleen E. Sullivan
Kathleen E. Sullivan
Beginning in 1970, a committee was constituted under the auspices of the World Health Organization (WHO) to catalog primary immunodeficiencies. Twenty years later, the International Union of Immunological Societies (IUIS) took the remit of this committee. The current report details the categorization and listing of 354 (as of February 2017) inborn errors of immunity. The growth and increasing complexity of the field have been impressive, encompassing an increasing variety of conditions, and the classification described here will serve as a critical reference for immunologists and researchers worldwide.

28 October 2013 in Nature Immunology
Verified
Journal Article
Closed access
PDF file
CLCarrie L Lucas
Carrie L Lucas
HKHye Sun Kuehn
Hye Sun Kuehn
FZFang Zhao
Fang Zhao
JNJulie E Niemela
Julie E Niemela
EDElissa K Deenick
Elissa K Deenick
GUGulbu Uzel
Gulbu Uzel